prnewswire.comFast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 20263 months ago
finance.yahoo.comFDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancersover 1 year ago
finance.yahoo.comZentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studiesover 1 year ago
finance.yahoo.comZentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024over 1 year ago
finance.yahoo.comZentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)over 1 year ago